Synthesis of Natural Acylphloroglucinol-Based Antifungal Compounds against Cryptococcus Species

Thirty-three natural-product-based acylphloroglucinol derivatives were synthesized to identify antifungal compounds against Cryptococcus spp. that cause the life-threatening disseminated cryptococcosis. In vitro antifungal testing showed that 17 compounds were active against C. neoformans ATCC 90113, C. neoformans H99, and C. gattii ATCC 32609, with minimum inhibitory concentrations (MICs) in the range 1.0-16,7 mu g/mL. Analysis of the structure and antifungal activity of thee compounds indicated that the 2,4-diacyl- and 2-acyl-4-alkylphloroglucinols were more active than O-alkyl-acylphloroglucinols. The most promising compound found was 2-methyl-1-(2,4,6-trihydroxy-3-(4-isopropylbenzyl)phenyl)-propan-1-one (11j), which exhibited potent antifungal activity (MICs, 1.5-2.1 mu g/mL) and low cytotoxicity against the mammalian Vero and LLC-PK1 cell lines (IC50 values >50 mu g/mL). This compound may serve as a template for further synthesis of new analogues with improved antifungal activity. The findings of the present work may contribute to future antifungal discovery toward pharmaceutical development of new treatments for cryptococcosis.